Clinical Trial Update: Kaletra and Viread in Antiretroviral Naïve Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial update on Kaletra and Viread in antiretroviral-naïve HIV patients; the study status is TERMINATED with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Kaletra (lopinavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Oklahoma State University Center for Health Sciences | Conditions: HIV Infections | Phase 4 | Status: TERMINATED | Results posted: 2020-12-04